Literature DB >> 28625678

Rapid protein production from stable CHO cell pools using plasmid vector and the cumate gene-switch.

Adeline Poulain1, Sylvie Perret2, Félix Malenfant2, Alaka Mullick2, Bernard Massie1, Yves Durocher3.   

Abstract

To rapidly produce large amounts of recombinant proteins, the generation of stable Chinese Hamster Ovary (CHO) cell pools represents a useful alternative to large-scale transient gene expression (TGE). We have developed a cell line (CHOBRI/rcTA) allowing the inducible expression of recombinant proteins, based on the cumate gene switch. After the identification of optimal plasmid DNA topology (supercoiled vs linearized plasmid) for PEIpro™ mediated transfection and of optimal conditions for methionine sulfoximine (MSX) selection, we were able to generate CHOBRI/rcTA pools producing high levels of recombinant proteins. Volumetric productivities of up to 900mg/L were reproducibly achieved for a Fc fusion protein and up to 350mg/L for an antibody after 14days post-induction in non-optimized fed-batch cultures. In addition, we show that CHO pool volumetric productivities are not affected by a freeze-thaw cycle or following maintenance in culture for over one month in the presence of MSX. Finally, we demonstrate that volumetric protein production with the CR5 cumate-inducible promoter is three- to four-fold higher than with the human CMV or hybrid EF1α-HTLV constitutive promoters. These results suggest that the cumate-inducible CHOBRI/rcTA stable pool platform is a powerful and robust system for the rapid production of gram amounts of recombinant proteins. Crown
Copyright © 2017. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CHO; Cell pools; Inducible expression system; Methionine sulfoximine; Polyethylenimine; Recombinant proteins

Mesh:

Substances:

Year:  2017        PMID: 28625678     DOI: 10.1016/j.jbiotec.2017.06.009

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  10 in total

1.  The role of protein hydrolysates in prolonging viability and enhancing antibody production of CHO cells.

Authors:  Ismael Obaidi; Letícia Martins Mota; Andrew Quigley; Michael Butler
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-01       Impact factor: 4.813

2.  Small-molecule inducible transcriptional control in mammalian cells.

Authors:  Aarti Doshi; Fatemeh Sadeghi; Navin Varadarajan; Patrick C Cirino
Journal:  Crit Rev Biotechnol       Date:  2020-08-30       Impact factor: 8.429

Review 3.  Expression vector cassette engineering for recombinant therapeutic production in mammalian cell systems.

Authors:  Tian-Yun Wang; Xiao Guo
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-06       Impact factor: 4.813

4.  Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.

Authors:  Aziza P Manceur; Howard Kim; Vanja Misic; Nadejda Andreev; July Dorion-Thibaudeau; Stéphane Lanthier; Alice Bernier; Sonia Tremblay; Anne-Marie Gélinas; Sophie Broussau; Rénald Gilbert; Sven Ansorge
Journal:  Hum Gene Ther Methods       Date:  2017-11-21       Impact factor: 2.396

5.  Enhanced anti-metastatic bioactivity of an IGF-TRAP re-engineered to improve physicochemical properties.

Authors:  George Vaniotis; Serge Moffett; Traian Sulea; Ni Wang; S Mehdy Elahi; Etienne Lessard; Jason Baardsnes; Stephanie Perrino; Yves Durocher; Jan Frystyk; Bernard Massie; Pnina Brodt
Journal:  Sci Rep       Date:  2018-11-26       Impact factor: 4.379

6.  Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.

Authors:  Baweleta Isho; Kento T Abe; Michelle Zuo; Alainna J Jamal; Bhavisha Rathod; Jenny H Wang; Zhijie Li; Gary Chao; Olga L Rojas; Yeo Myong Bang; Annie Pu; Natasha Christie-Holmes; Christian Gervais; Derek Ceccarelli; Payman Samavarchi-Tehrani; Furkan Guvenc; Patrick Budylowski; Angel Li; Aimee Paterson; Feng Yun Yue; Lina M Marin; Lauren Caldwell; Jeffrey L Wrana; Karen Colwill; Frank Sicheri; Samira Mubareka; Scott D Gray-Owen; Steven J Drews; Walter L Siqueira; Miriam Barrios-Rodiles; Mario Ostrowski; James M Rini; Yves Durocher; Allison J McGeer; Jennifer L Gommerman; Anne-Claude Gingras
Journal:  Sci Immunol       Date:  2020-10-08

7.  Manipulating cellular microRNAs and analyzing high-dimensional gene expression data using machine learning workflows.

Authors:  Vijit Saini; Mugdha V Joglekar; Wilson K M Wong; Guozhi Jiang; Najah T Nassif; Ann M Simpson; Ronald C W Ma; Louise T Dalgaard; Anandwardhan A Hardikar
Journal:  STAR Protoc       Date:  2021-10-23

8.  Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models.

Authors:  Martin A Rossotti; Henk van Faassen; Anh T Tran; Joey Sheff; Jagdeep K Sandhu; Diana Duque; Melissa Hewitt; Xiaoxue Wen; Jegarubee Bavananthasivam; Saina Beitari; Kevin Matte; Geneviève Laroche; Patrick M Giguère; Christian Gervais; Matthew Stuible; Julie Guimond; Sylvie Perret; Greg Hussack; Marc-André Langlois; Yves Durocher; Jamshid Tanha
Journal:  Commun Biol       Date:  2022-09-09

9.  Decoupling Growth and Protein Production in CHO Cells: A Targeted Approach.

Authors:  James S Donaldson; Matthew P Dale; Susan J Rosser
Journal:  Front Bioeng Biotechnol       Date:  2021-06-02

10.  A simple protein-based surrogate neutralization assay for SARS-CoV-2.

Authors:  Kento T Abe; Zhijie Li; Reuben Samson; Payman Samavarchi-Tehrani; Emelissa J Valcourt; Heidi Wood; Patrick Budylowski; Alan P Dupuis; Roxie C Girardin; Bhavisha Rathod; Jenny H Wang; Miriam Barrios-Rodiles; Karen Colwill; Allison J McGeer; Samira Mubareka; Jennifer L Gommerman; Yves Durocher; Mario Ostrowski; Kathleen A McDonough; Michael A Drebot; Steven J Drews; James M Rini; Anne-Claude Gingras
Journal:  JCI Insight       Date:  2020-10-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.